Analysts Conflicted on These Real Estate Names: AG Mortgage (MITT), Regency Centers (REG) and Healthpeak Properties (DOC)
Analysts have been eager to weigh in on the Real Estate sector with new ratings on AG Mortgage (MITT), Regency Centers (REG) and Healthpeak Properties (DOC).
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AG Mortgage (MITT)
Piper Sandler analyst Crispin Love maintained a Buy rating on AG Mortgage today and set a price target of $10.00. The company’s shares closed last Wednesday at $7.26.
According to TipRanks.com, Love is a 4-star analyst with an average return of
Currently, the analyst consensus on AG Mortgage is a Strong Buy with an average price target of $9.31, representing a 26.8% upside. In a report issued on March 26, TipRanks – Google also reiterated a Buy rating on the stock with a $8.00 price target.
See the top stocks recommended by analysts >>
Regency Centers (REG)
BTIG analyst Michael Gorman maintained a Buy rating on Regency Centers today and set a price target of $79.00. The company’s shares closed last Wednesday at $76.11, close to its 52-week high of $78.18.
According to TipRanks.com, Gorman is a 4-star analyst with an average return of
Currently, the analyst consensus on Regency Centers is a Moderate Buy with an average price target of $81.36, representing a 7.8% upside. In a report issued on March 19, BMO Capital also maintained a Buy rating on the stock.
Healthpeak Properties (DOC)
Cantor Fitzgerald analyst Richard Anderson reiterated a Hold rating on Healthpeak Properties yesterday and set a price target of $17.00. The company’s shares closed last Wednesday at $16.38.
According to TipRanks.com, Anderson is a 4-star analyst with an average return of
Currently, the analyst consensus on Healthpeak Properties is a Moderate Buy with an average price target of $18.61, representing a 13.5% upside. In a report released yesterday, Citi also maintained a Hold rating on the stock with a $17.50 price target.
Read More on MITT:
